ORYZON to Present at the 11th Annual BIO-Europe Spring International Partnering Conference

BARCELONA, SPAIN and CAMBRIDGE MA.

Oryzon Genomics (Madrid Stock Exchange: ORY) (ISIN Code: ES0167733015), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that Dr. Carlos Buesa, Oryzon’s Chief Executive Officer, is scheduled to present at the 11th Annual BIO-Europe Spring International Partnering Conference being held in Barcelona, Spain March 20-22, 2017 at the CCIB Convention Center in Barcelona, Spain.

Click here to see the full Press Release